| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50e5b3009e03b0e1350fee76912a9dec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f74ab5be251cd9cd1f482cc1e324e7f0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-93 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 |
| filingDate |
2002-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8b5eded0f7c146df7d2e0b41d7225e5 |
| publicationDate |
2002-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02079459-A2 |
| titleOfInvention |
Means for inhibiting proteolytical processing of parkin |
| abstract |
An isolated nucleic acid sequence encoding a polypeptide functionally homologous to the wild type form of the Parkin polypeptide or a fragment of said polypeptide, the amino acid sequence of said polypeptide differing from the wild type amino acid sequence at least in including a mutation at Asp 126, wherein the said nucleic acid sequence is at least 70% identical to a nucleic acid sequence encoding the wild type Parkin polypeptide, and a mutated Parkin polypeptide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8017348-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2002344677-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007089334-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007089334-A2 |
| priorityDate |
2001-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |